MAI Capital Management’s Cidara Therapeutics CDTX Stock Holding History

MAI Capital Management’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2	Closed	-$442	–	5038
2025 Q4	$442	Sell	2 -5	-71%	-$808	﹤0.01%	3864
2025 Q3	$671	Buy	+7	New	+$447	﹤0.01%	3571

MAI Capital Management's CDTX Position: Q1 2026 in Review

MAI Capital Management sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 2 shares — an estimated $442 sold.

MAI Capital Management first reported a position in CDTX in Q3 2025 and held it in 2 quarters. The position peaked at $671 in Q3 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

MAI Capital Management reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
MAI Capital Management sold 2 Cidara Therapeutics shares in Q1 2026, an estimated $442.
MAI Capital Management first reported a position in Cidara Therapeutics in Q3 2025 and held it in 2 quarters.
MAI Capital Management's Cidara Therapeutics position peaked at $671 in Q3 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.